Aeirtec has provided multiplexing biomarker services in Biotech phase 2 and 3 clinical studies for 20 years
- Now with unique advanced measurement technology.
Our Service
Our service is provided across multiple therapeutic areas, and is fully customisable.
Our high sensitivity technology provides multiplexing of marker measurement by custom or fixed marker panels.
Our technology is successful in delivering surrogate demonstration of clinical efficacy and mechanism of action.
Our service is conducted under the principles of GLP and ISO17025:2017.
Example Panels
-
Allergy Panel
-
Autoimmune Panel
-
ARDS Panel
-
Stroke Panel